Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.64

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.25

Views

Views
April 20252
May 20250
June 20253
July 202517
August 20250
September 20252
October 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil10
United States6
Spain2
Kenya2
Argentina2
Germany1
United Kingdom1
South Africa1
 

Top cities views

Views
Arlington Heights1
Cape Town1
Cedar Rapids1
Chattanooga1
Council Bluffs1
Coventry1
Ituiutaba1
Lomas de Zamora1
Mercedes1
Munich1